Conclusion The proliferation of misleading advertisements for GLP-1 RAs on social media, often from influencers & celebrities, warrants the recognition of an exception to the learned intermediary doctrine for GLP-1 RA drugs
Biocytogens suite of humanized receptor mouse models offers a powerful translational platform to validate receptor-specific pharmacology and cross-species activity of these advanced molecules in a human-relevant context
The NO-mediated inhibition of sarco/endoplasmic reticulum calcium ATPase pumps was believed to facilitate sustained calcium release, thereby increasing cytosolic calcium concentrations and cross-bridge formation (Stamler and Meissner, 2001
Gordaliza-Alaguero I, Snchez-Fernndez-de-Landa P, Radivojevikj D, Villarreal L, Arauz-Garofalo G, Gay M, et al
Effects of Other Drugs on Sitagliptin Clinical data described below suggest that sitagliptin is not susceptible to clinically meaningful interactions by co-administered medications
Retatrutide is an investigational compound and is not an approved medicine in any jurisdiction as of April 2026